(KIDS) Orthopediatrics - Ratings and Ratios

OrthoPediatrics Corp. (NASDAQ:KIDS) is a specialized medical device company focused on designing, developing, and marketing orthopedic implants, instruments, and braces tailored for pediatric patients. The company addresses the unique needs of children with orthopedic conditions, offering a comprehensive portfolio of solutions for trauma, deformity correction, scoliosis, and sports medicine. Its product range includes the PediLoc, PediPlates, PediFlex nail, PediNail, ACL Reconstruction System, and the GIRO Growth Modulation System, among others. These devices are designed to accommodate growth and developmental needs of pediatric patients, providing anatomically appropriate solutions. The company serves a niche market, primarily targeting pediatric orthopedic surgeons and caregivers. Founded in 2006, OrthoPediatrics is headquartered in Warsaw, Indiana, a hub for orthopedic innovation.

From a financial perspective, OrthoPediatrics Corp. operates with a market capitalization of $575.37 million. The company currently reports a price-to-book ratio of 1.59 and a price-to-sales ratio of 3.03. Its return on equity stands at -7.67%, reflecting ongoing investments in growth and product development. The stock is trading at $22.89, below its 20-day and 50-day simple moving averages of $24.10 and $24.16, respectively. The 200-day SMA of $27.63 indicates a longer-term downtrend. Average trading volume over the past 20 days is approximately 306,550 shares, with an average true range (ATR) of 1.27, suggesting moderate volatility.